Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Elanco Animal Health is experiencing a notable surge, having increased by 17% in August, a reflection of positive market dynamics within the animal health sector, which is renowned for its expansive growth potential. The company boasts a solid product pipeline, with revenues from all products demonstrating a healthy increase from $350-400 million to $450 million. Analysts view the stock favorably, noting its appealing valuation metrics, such as a price-to-earnings ratio of 14x and a price-to-book ratio of 1x. These figures suggest that the stock may be undervalued relative to its growth prospects and industry benchmarks. As the animal health industry continues to grow, Elanco is positioned well to leverage these trends and deliver value to its shareholders.
Spun off from Eli Lilly in 2018. Reported a mixed report today, including their pet business missing as guidance for the current quarter fell short. They will sell its Aqua business to Merck Animal Health, announced restructuring/job cuts and will increase cash flow conversions four times this year, which is a priority. This gives him some hope in the name.
Elanco Animal Health is a American stock, trading under the symbol ELAN-N on the New York Stock Exchange (ELAN). It is usually referred to as NYSE:ELAN or ELAN-N
In the last year, 2 stock analysts published opinions about ELAN-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Elanco Animal Health.
Elanco Animal Health was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Elanco Animal Health.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Elanco Animal Health published on Stockchase.
On 2025-05-09, Elanco Animal Health (ELAN-N) stock closed at a price of $11.96.
Is up 17% in August. It's all about animal health, an enormous industry. They have a fine product pipeline, and all products' revenues have climbed from $350-400 million to $450 million. Cheap at 14x PE and 1x book.